Sonnet BioTherapeutics Holdings, Inc. (SONN) News

Sonnet BioTherapeutics Holdings, Inc. (SONN): $1.25

0.10 (+8.23%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add SONN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#264 of 320

in industry

Filter SONN News Items

SONN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!